Results for tag: Stephen Ansell Total Items Found: 5

Encouraging Results With Pembrolizumab in Relapsed/Refractory Classical Hodgkin Lymphoma

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 7/6/2017 1:43:39 PM

Stephen M. Ansell, MD, PhD, on Hematologic Malignancies: Results of the CheckMate 039 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASH 2016
Stephen Ansell
Mayo Clinic
CheckMate 039
nivolumab
ipilimumab
hematologic malignancy

Created: 12/5/2016 2:41:40 PM

Nivolumab in Recurrent Classical Hodgkin Lymphoma: Refreshingly Supportive Data

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 9/7/2016 3:05:59 PM

Stephen M. Ansell, MD, PhD, on Precision Immunotherapy for Refractory Hodgkin Lymphoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Pan-Pacific Lymphoma 2016
Stephen Ansell
refractory Hodgkin lymphoma
Mayo Clinic
nivolumab
pembrolizumab

Created: 7/20/2016 10:40:25 AM

Brentuximab Vedotin After Autologous Stem Cell Transplantation in High-Risk Hodgkin Lymphoma: Implications of the AETHERA Trial

Type of Page:TapArticle
Edit This Item
Tags for this item:

Created: 1/7/2016 4:57:13 PM
Order By Item Count
Order Alphabetically